Alexandre Grassin
Corporate Officer/Principal bei Calliditas Therapeutics Suisse SA
Aktive Positionen von Alexandre Grassin
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Calliditas Therapeutics Suisse SA
Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland. | Corporate Officer/Principal | - | - |
Chief Administrative Officer | 04.01.2012 | - | |
Director of Finance/CFO | 04.01.2012 | 14.01.2015 |
Karriereverlauf von Alexandre Grassin
Ehemalige bekannte Positionen von Alexandre Grassin
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ENGENE HOLDINGS INC. | Director of Finance/CFO | 01.07.2023 | 29.11.2023 |
Alexion Pharma GmbH | Corporate Officer/Principal | 01.01.2010 | 01.01.2012 |
NOVARTIS AG | Corporate Officer/Principal | 01.01.2007 | 01.01.2010 |
GENKYOTEX SA. | Chief Administrative Officer | 01.04.2012 | - |
Director of Finance/CFO | 01.04.2012 | - | |
KPMG SA
KPMG SA Miscellaneous Commercial ServicesCommercial Services KPMG SA provides auditing and accounting solutions. It intervenes in the insurance, asset management, real estate, automobile, and telecommunications sectors. The firm offers risk advisory, tax and regulatory, and financial advisory services. The company was founded in 1986 and is headquartered in Paris, France. | Corporate Officer/Principal | 01.01.2001 | - |
Statistik
International
Schweiz | 4 |
Frankreich | 3 |
Kanada | 2 |
Operativ
Corporate Officer/Principal | 4 |
Director of Finance/CFO | 3 |
Chief Administrative Officer | 2 |
Sektoral
Health Technology | 5 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
NOVARTIS AG | Health Technology |
ENGENE HOLDINGS INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
Calliditas Therapeutics Suisse SA
Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland. | Health Technology |
KPMG SA
KPMG SA Miscellaneous Commercial ServicesCommercial Services KPMG SA provides auditing and accounting solutions. It intervenes in the insurance, asset management, real estate, automobile, and telecommunications sectors. The firm offers risk advisory, tax and regulatory, and financial advisory services. The company was founded in 1986 and is headquartered in Paris, France. | Commercial Services |
Alexion Pharma GmbH | |
Calliditas Therapeutics France SAS
Calliditas Therapeutics France SAS Pharmaceuticals: MajorHealth Technology Calliditas Therapeutics France SAS is a biopharmaceutical company, which engages in the NOX therapies. Its therapeutic approach is based on a selective inhibition of NOX enzymes that amplify multiple disease processes, such as fibrosis, inflammation, pain processing, cancer development, and eurodegeneration. The firm’s platform enables the identification of orally available small molecules that selectively inhibit specific NOX enzymes. The company was founded in 2006 and is headquartered in Saint-Julien-en-Genevois, France. | Health Technology |
- Börse
- Insiders
- Alexandre Grassin
- Erfahrung